Abstract
Hepatic lipase (HL) is necessary for efficient clearance of triglyceride-rich lipoproteins from plasma (1). In humans, HL deficiency leads to the accumulation of triglyceride-rich intermediate density lipoproteins (IDL), LDL, and large HDL (2–4). Inhibition of hepatic lipase in rats with specific antibodies to HL (5–12) causes similar changes in plasma lipoprotein patterns, with accumulation of IDL and chylomicron remnants in the low density ranges and increases in the large HDL subfractions. In isolated, perfused rat livers inhibition of hepatic lipase with antibodies or removal of HL by heparin perfusion reduces the uptake of chylomicron remnants (13). Finally, recent studies with cultured hepatoma cells over-expressing human HL (14) demonstrate a threefold increase in binding and uptake of β-VLDL and chylomicron remnants when compared to non-transfected cells. Hence, several studies have shown that decreased HL activity inhibits clearance of triglyceride-rich lipoproteins, while overexpression of HL facilitates clearance of these particles.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Jansen, H. and Hülmann, W. C. (1985) Enzymology and physiological role of hepatic lipase. Biochem. Soc. Trans. 13, 24–26.
Hegele, R. A., Vezina, C., Moorjani, S., Lupien, P. J., Gagne, C., Brun, L. D., Little, J. A., and Connelly, P. W., (1991) A hepatic lipase gene mutation associated with heritable lipolytic deficiency. J. Clin. Endocrinol. Metab. 72, 730–732.
Connelly, P. W., Maguire, G. F., Lee, M. and Little, J. A. (1990) Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis 10, 40–48
Hegele, R. A., Little, J. A., Vezina, C., Maguire, G. F., Tu, L., Wolever, T. S., Jenkins, D. J. A., and Connelly, P. W. (1993) Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler. Thromb. 13, 720–728.
Goldberg, I. J., Lee, N. A., Paterniti, J. R., Jr., Ginsberg, H. N., Lindgren, F. T., and Brown, W. V. (1992) Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomologus monkey. J. Clin. Invest. 70, 1184–1192.
Kuusi, T., Kinnunen, P. K. J., and Nikkila, E. A. (1979) Hepatic endothelial lipase antiserum influences rat plasma low and high density lipoproteins in vivo. FEBS Lett. 104, 384–388.
Jansen, H., van Tol, A. and Hülsmann, W. C. (1980) On the metabolic function of heparin-releasable liver lipase. Biochem. Biophys. Res. Commun. 92, 53–59.
Grosser, J., Schrecker, O., and Greten, H. (1981) Function of hepatic triglyceride lipase in lipoprotein metabolism. J. Lipid Res. 22, 437–442.
Daggy, B. P. and Bensadoun, A. (1986) Enrichment of apolipoprotein B-48 in the LDL density class following in vivo inhibition of hepatic lipase. Biochim. Biophys. Acta 877, 252–261.
Demacker, P. N. M., Hijmans, A. G. M., Stalenhoef, A. F. H., and van’t Laar (1988) Studies on the function of hepatic lipase in the cat after immunological blockade of the enzyme in vivo. Atherosclerosis 69, 173–183.
Murase, T. and Itakura, H. (1981) Accumulation of intermediate density lipoprotein after intravenous administration of hepatic triglyceride lipase antibody in rats. Atherosclerosis 39, 293–300.
Sultan, F., Lagrange, D., Jansen, H. and Griglio, S. (1990) Inhibition of hepatic lipase activity impairs chylomicron remnant removal in rats. Biochim. Biophys. Acta 1042, 150–152.
Shafi, S., Brady, S. E., Bensadoun, A. and Havel, R. J. (1994) Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J. Lipid Res. 35, 709–720.
Ji, Z. S., Lauer, S. J., Fazio, S., Bensadoun, A., Taylor, J. M., and Mahley, R. W. (1994) Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J. Biol. Chem. 269, 23,838–23,844.
Umbreit, W. W., Burris, R. H., and Stauffer, J. F. (1957) Manometric Techniques, Burgess, pp. 149.
Cisar, L. A. and Bensadoun, A. (1985) Enzyme-linked immunosorbent assay for rat hepatic triglyceride lipase. J. Lipid Res. 26, 380–386.
Brasaemle, D., Cornely-Moss, K., and Bensadoun, A. (1993) Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E. J. Lipid Res. 34, 455–465.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc, Totowa, NJ
About this protocol
Cite this protocol
Bensadoun, A., Hughes, B., Melford, K., Hsu, J., Braesaemle, D.L. (1999). Purification of Rat Hepatic Lipase Essentially Free of Apolipoprotein E and Apolipoprotein B. In: Doolittle, M., Reue, K. (eds) Lipase and Phospholipase Protocols. Methods in Molecular Biology™, vol 109. Humana Press. https://doi.org/10.1385/1-59259-581-2:151
Download citation
DOI: https://doi.org/10.1385/1-59259-581-2:151
Publisher Name: Humana Press
Print ISBN: 978-0-89603-546-1
Online ISBN: 978-1-59259-581-5
eBook Packages: Springer Protocols